The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Abstract
Asthma is a chronic inflammatory disease of the airways that is challenging to dissect into subgroups because of the heterogeneity present across the spectrum of the disease. Efforts to subclassify asthma using advanced computational methods have identified a number of different phenotypes that suggest that multiple pathobiologically driven clusters of disease exist. The main phenotypes that have been identified include (1) early-onset allergic asthma, (2) early-onset allergic moderate-to-severe remodeled asthma, (3) late-onset nonallergic eosinophilic asthma, and (4) late-onset nonallergic noneosinophilic asthma. Subgroups of these phenotypes also exist but have not been as consistently identified. Advances in our understanding of the diverse immunologic perturbations that drive airway inflammation are consistent with clinical traits associated with these phenotypes and their response to biologic therapies. This has improved the clinician's approach to characterizing asthmatic patients in the clinic. Being able to define asthma endotypes using clinical characteristics and biomarkers will move physicians toward even more personalized management of asthma and precision-based care in the future. Here we will review the most prominent phenotypes and immunologic advances that suggest these disease subtypes represent asthma endotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
Asthma phenotypes: the evolution from clinical to molecular approaches
Wenzel, S. E. (2012) · Nature Medicine · doi:10.1038/nm.2678 · Cited by 2,412
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
Type 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654
Bleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
FitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Kuruvilla, M. E., Lee, F. E.-H., & Lee, G. B. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8712-1 · Cited by 1,228
Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010.
Akinbami, L. J., Moorman, J. E., Bailey, C., Zahran, H. S., King, M., Johnson, C. A., & Liu, X. (2012) · PubMed · Cited by 1,188
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Anderson, G. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61452-x · Cited by 999
Tezepelumab in Adults with Uncontrolled Asthma
Corren, J., Parnes, J. R., Wang, L., Mo, M., Roseti, S. L., Griffiths, J. M., & van der Merwe, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704064 · Cited by 965
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
SIMPSON, J. L., SCOTT, R., BOYLE, M. J., & GIBSON, P. G. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00784.x · Cited by 955
Halim, T. Y. F., Krauß, R. H., Sun, A. C., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.020 · Cited by 804
Thaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572
Ortega, H. G., Yancey, S. W., Mayer, B., Gunsoy, N. B., Keene, O. N., Bleecker, E. R., Brightling, C. E., & Pavord, I. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30031-5 · Cited by 559
A Chitinase-like Protein in the Lung and Circulation of Patients with Severe Asthma
Chupp, G. L., Lee, C. G., Jarjour, N., Shim, Y. M., Holm, C. T., He, S., Dziura, J. D., Reed, J., Coyle, A. J., Kiener, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073600 · Cited by 547
Self-citationPeters, M. C., McGrath, K. W., Hawkins, G. A., Hastie, A. T., Levy, B. D., Israel, E., Phillips, B. R., Mauger, D. T., Comhair, S. A., Erzurum, S. C., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30048-0 · Cited by 543
Commonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J., & Gibson, P. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1134oc · Cited by 482
Wolterink, R. G. J. K., KleinJan, A., van Nimwegen, M., Bergen, I., de Bruijn, M., Levani, Y., & Hendriks, R. W. (2012) · European Journal of Immunology · doi:10.1002/eji.201142018 · Cited by 473
Smith, S. G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.-P., O'Byrne, P. M., Gauvreau, G. M., Boulet, L.-P., Lemiere, C., Martin, J., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.037 · Cited by 459
Exhaled Nitric Oxide in Pulmonary Diseases
Barnes, P. J., Dweik, R. A., Gelb, A. F., Gibson, P. G., George, S. C., Grasemann, H., Pavord, I. D., Ratjen, F., Silkoff, P. E., Taylor, D. R., et al. (2010) · Chest · doi:10.1378/chest.09-2090 · Cited by 393
Induced Sputum Cell Counts in Healthy Adults
BELDA, J., LEIGH, R., PARAMESWARAN, K., O'BYRNE, P. M., SEARS, M. R., & HARGREAVE, F. E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9903097 · Cited by 389
Anti-inflammatory activity of macrolide antibiotics
Michie, C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02441-3 · Cited by 356
Untangling asthma phenotypes and endotypes
Agache, I., Akdis, C., Jutel, M., & Virchow, J. C. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02832.x · Cited by 345
Anti-inflammatory effects of macrolide antibiotics
Čulić, O., Eraković, V., & Parnham, M. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01321-8 · Cited by 334
Innate immune activation in neutrophilic asthma and bronchiectasis
Simpson, J. L., Grissell, T. V., Douwes, J., Scott, R. J., Boyle, M. J., & Gibson, P. G. (2007) · Thorax · doi:10.1136/thx.2006.061358 · Cited by 331
Agache, I., & Akdis, C. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124611 · Cited by 313
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Lefaudeux, D., De Meulder, B., Loza, M. J., Peffer, N., Rowe, A., Baribaud, F., Bansal, A. T., Lutter, R., Sousa, A. R., Corfield, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.048 · Cited by 290
Innate and adaptive type 2 immunity in lung allergic inflammation
Kubo, M. (2017) · Immunological Reviews · doi:10.1111/imr.12557 · Cited by 269
Increased serum IL-17 is an independent risk factor for severe asthma
Agache, I., Ciobanu, C., Agache, C., & Anghel, M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.018 · Cited by 262
Hastie, A. T., Moore, W. C., Li, H., Rector, B. M., Ortega, V. E., Pascual, R. M., Peters, S. P., Meyers, D. A., & Bleecker, E. R. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.044 · Cited by 260
Asthma Endotypes and an Overview of Targeted Therapy for Asthma
Svenningsen, S., & Nair, P. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00158 · Cited by 252
Pizzichini, E., Pizzichini, M. M., Efthimiadis, A., Dolovich, J., & Hargreave, F. E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70082-4 · Cited by 229
Busse, W., Chupp, G., Nagase, H., Albers, F. C., Doyle, S., Shen, Q., Bratton, D. J., & Gunsoy, N. B. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.031 · Cited by 209
Self-citationGhazi, A., Trikha, A., & Calhoun, W. J. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.642359 · Cited by 189
Severe eosinophilic asthma: a roadmap to consensus
Buhl, R., Humbert, M., Bjermer, L., Chanez, P., Heaney, L. G., Pavord, I., Quirce, S., Virchow, J. C., & Holgate, S. (2017) · European Respiratory Journal · doi:10.1183/13993003.00634-2017 · Cited by 188
Chambers, E. S., Nanzer, A. M., Pfeffer, P. E., Richards, D. F., Timms, P. M., Martineau, A. R., Griffiths, C. J., Corrigan, C. J., & Hawrylowicz, C. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.026 · Cited by 179
Proinflammatory Pathways in the Pathogenesis of Asthma
Peebles, R. S., & Aronica, M. A. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.10.014 · Cited by 179
Omalizumab and the risk of malignancy: Results from a pooled analysis
Busse, W., Buhl, R., Fernandez Vidaurre, C., Blogg, M., Zhu, J., Eisner, M. D., & Canvin, J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.033 · Cited by 171
Miljkovic, D., Bassiouni, A., Cooksley, C., Ou, J., Hauben, E., Wormald, P. ‐., & Vreugde, S. (2014) · Allergy · doi:10.1111/all.12440 · Cited by 167
Management of the patient with eosinophilic asthma: a new era begins
de Groot, J. C., ten Brinke, A., & Bel, E. H. D. (2015) · ERJ Open Research · doi:10.1183/23120541.00024-2015 · Cited by 161
Bellini, A., Marini, M. A., Bianchetti, L., Barczyk, M., Schmidt, M., & Mattoli, S. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.60 · Cited by 158
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma
Weinstein, S. F., Katial, R. K., Jayawardena, S., Pirozzi, G., Staudinger, H. W., Eckert, L., Joish, V. N., Amin, N., Maroni, J. M., Rowe, P., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.051 · Cited by 155
“T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Pavlidis, S. P., Takahashi, K., Kwong, F. N. K., Xie, J., Hoda, U., Sun, K., Elyasigomari, V., Agapow, P., Loza, M. J., Baribaud, F., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00938-2018 · Cited by 155
Tran, T. N., Zeiger, R. S., Peters, S. P., Colice, G., Newbold, P., Goldman, M. A., & Chipps, B. E. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.10.027 · Cited by 144
Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights
Komi, D. E. A., & Bjermer, L. H. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8720-1 · Cited by 140
Gabryelska, A., Kuna, P., Antczak, A. J., Białasiewicz, P., & Panek, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00692 · Cited by 135
Pathogenic memory type Th2 cells in allergic inflammation
Endo, Y., Hirahara, K., Yagi, R., Tumes, D. J., & Nakayama, T. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.11.003 · Cited by 127
Ten-Year Follow-up of Cluster-based Asthma Phenotypes in Adults. A Pooled Analysis of Three Cohorts
Boudier, A., Curjuric, I., Basagaña, X., Hazgui, H., Antó, J. M., Bousquet, J. J., Bridevaux, P., Dupuis‐Lozeron, E., García‐Aymerich, J., Heinrich, J., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0156oc · Cited by 126
Clinical profile of patients with adult-onset eosinophilic asthma
de Groot, J. C., Storm, H., Amelink, M., de Nijs, S. B., Eichhorn, E., Reitsma, B. H., Bel, E. H., & Brinke, A. T. (2016) · ERJ Open Research · doi:10.1183/23120541.00100-2015 · Cited by 125
IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response
Jia, Y., Fang, X., Zhu, X., Bai, C., Zhu, L., Jin, M., Wang, X., Hu, M., Tang, R., & Chen, Z. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0099oc · Cited by 125
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Holgate, S. T., Buhl, R., Bousquet, J. J., Smith, N., Panahloo, Z., & Jimenez, P. A. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.03.008 · Cited by 119
Ortega, H. G., Li, H., Suruki, R., Albers, F. C., Gordon, D., & Yancey, S. W. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-454oc · Cited by 116
Noninvasive Analysis of the Sputum Transcriptome Discriminates Clinical Phenotypes of Asthma
Yan, X., Chu, J., Gómez, J. L., Koenigs, M., Holm, C. T., He, X., Perez, M. F., Zhao, H., Mane, S., Martínez, F. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1440oc · Cited by 114
Self-citationThe prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
Domingo, C., Palomares, Ó., Sandham, D. A., Erpenbeck, V. J., & Altman, P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0893-x · Cited by 103
T2-low asthma: current approach to diagnosis and therapy
Samitas, Κ., Ζervas, Ε., & Gaga, M. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000342 · Cited by 101
Group 2 innate lymphoid cells and asthma
Kabata, H., Moro, K., Koyasu, S., & Asano, K. (2015) · Allergology International · doi:10.1016/j.alit.2015.03.004 · Cited by 95
Borish, L. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.04.022 · Cited by 87
Innate lymphoid cells in asthma: Will they take your breath away?
Kim, H. Y., Umetsu, D. T., & DeKruyff, R. H. (2016) · European Journal of Immunology · doi:10.1002/eji.201444557 · Cited by 85
Gao, J., & Wu, F. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0248-7 · Cited by 82
MacDonald, K., Kavati, A., Ortiz, B. D., Alhossan, A., Lee, C. S., & Abraham, I. L. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1574571 · Cited by 79
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy
Pelaia, C., Vatrella, A., Bruni, A., Terracciano, R., & Pelaia, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s155307 · Cited by 78
Wan, X. C., & Woodruff, P. G. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.03.004 · Cited by 75
Wang, F., Liu, T., Zhu, L., Li, S., & Mao, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166833 · Cited by 68
Exhaled Nitric Oxide in Asthma
Grob, N. M., & Dweik, R. A. (2008) · CHEST Journal · doi:10.1378/chest.07-2743 · Cited by 62
Characterisation of asthma subgroups associated with circulating YKL-40 levels
Gómez, J. L., Yan, X., Holm, C. T., Grant, N., Liu, Q., Cohn, L. E., Nezgovorova, V., Meyers, D. A., Bleecker, E. R., Crisafi, G. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00800-2017 · Cited by 60
Self-citationImproving the diagnosis of eosinophilic asthma
Coumou, H., & Bel, E. H. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1236688 · Cited by 58
Phenotype-Driven Therapeutics in Severe Asthma
Opina, M. T. D., & Moore, W. C. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0678-1 · Cited by 48
Airway Inflammation and Inflammatory Biomarkers
Lim, H. F., & Nair, P. K. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1606217 · Cited by 43
Chen, J., Qin, L., Shi, Y., Feng, J., Zheng, Y., Wan, Y.-F., Xu, C., Yang, X.-M., & Hu, C. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.10.018 · Cited by 35
Longitudinal Changes in Asthma Control with Omalizumab: 2-Year Interim Data from the EXCELS Study
Eisner, M. D., Zazzali, J. L., Miller, M. K., Bradley, M. S., & Schatz, M. X. (2012) · Journal of Asthma · doi:10.3109/02770903.2012.690477 · Cited by 32
Boudier, A., Chanoine, S., Accordini, S., Antó, J. M., Basagaña, X., Bousquet, J. J., Demoly, P. M., García‐Aymerich, J., Gormand, F., Heinrich, J., et al. (2018) · Allergy · doi:10.1111/all.13697 · Cited by 25
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Precision Medicine: Disease Subtyping and Tailored Treatment
Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 315
Current State and Prospects of Artificial Intelligence in Allergy
van Breugel, M., Fehrmann, R. S. N., Bügel, M., Rezwan, F. I., Holloway, J. W., Nawijn, M. C., Fontanella, S., Custovic, A., & Koppelman, G. H. (2023) · Allergy · doi:10.1111/all.15849 · Cited by 43
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
Giombi, F., Pace, G. M., Pirola, F., Cerasuolo, M., Ferreli, F., Mercante, G., Spriano, G., Canonica, G. W., Heffler, E., Ferri, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020730 · Cited by 25
Lemmetyinen, R., Karjalainen, J., But, A., Renkonen, R., Pekkanen, J., Haukka, J., & Toppila-Salmi, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053133 · Cited by 7
Metadata
- Authors
- Kaur, R., & Chupp, G.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 144
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2955025518
- Cited by
- 457
- References
- 78
- FWCI
- 28.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.